Error: Could not add to watchlist. X
+ Watchlist

Catalyst Biosciences Inc

TRGT:US
Ticker Change
TRGT:US has changed to a new ticker symbol
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding (m)
11.417
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Catalyst Biosciences Inc. is a clinical-stage biopharmaceutical company. The Company creates and develops medicines to address medical conditions in the fields of hemostasis, including treatment of hemophilia and surgical bleeding, and inflammation, including prevention of transplant rejection, age-related macular degeneration, cardiovascular disease, asthma, and autoimmune disease.
Address
260 Littlefield Avenue
San Francisco, CA 94080
United States
Phone
1-650-266-8674
Show More